This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Modernatx, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Raffael Nachbagauer: Innovator in RNA Vaccines
Introduction
Raffael Nachbagauer is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of vaccine development, particularly focusing on RNA vaccines for seasonal influenza.
Latest Patents
Raffael holds a patent for "Seasonal RNA influenza virus vaccines." This patent provides innovative RNA vaccines for seasonal influenza virus, along with methods for utilizing these vaccines effectively. He has 1 patent to his name, showcasing his expertise in this critical area of research.
Career Highlights
Raffael is currently employed at ModernaTX, Inc., a leading biotechnology company known for its groundbreaking work in mRNA technology. His role at the company allows him to contribute to the development of cutting-edge vaccines that have the potential to save lives.
Collaborations
Raffael has collaborated with notable colleagues, including Carole Henry and Patricia Jorquera. These partnerships enhance the research and development efforts at ModernaTX, Inc., fostering innovation in vaccine technology.
Conclusion
Raffael Nachbagauer is a key figure in the advancement of RNA vaccines, with a focus on seasonal influenza. His work at ModernaTX, Inc. and his patent contributions highlight his commitment to improving public health through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile